Press release
Aorto-Iliac Occlusive Disease Treatment Market Projected to Reach USD 3.56 Billion by 2034, Expanding at a CAGR of 5.3%
Aorto-Iliac Occlusive Disease Treatment Market
The report analyzes the market for aorto-iliac occlusive disease treatment to register a CAGR of 5.3% during 2025-2034. The market was valued at USD 2.12 billion in 2024 and is anticipated to reach USD 3.56 billion by 2034.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/aorto-iliac-occlusive-disease-treatment-market/request-for-sample
Market Overview:
Aorto-iliac occlusive disease (AIOD) treatment focuses on restoring adequate blood flow in patients with narrowing or blockage of the aorta and iliac arteries. This condition is typically caused by atherosclerosis, which is plaque buildup that reduces arterial blood flow. Treatment options vary based on the severity of the disease and the overall health of the patient. In the early stages, conservative management includes lifestyle modifications such as smoking cessation, structured exercise programs, and the use of medications. For more severe cases, minimally invasive endovascular procedures such as angioplasty are commonly used to open narrowed arteries. In patients with extensive occlusions surgical revascularization, like aorto-bifemoral bypass grafting, may be performed.
Market Dynamics:
Rising Prevalence of Peripheral Arterial Disease (PAD): The rising number of people being affected by lifestyle-related conditions such as high blood pressure, diabetes, and obesity has led to a higher risk of peripheral arterial disease (PAD. These health issues lead to damaged blood vessels over time, making individuals more prone to blockages in major arteries. As a result, more patients are being diagnosed with aorto-iliac occlusive disease. This is creating higher demand for effective treatment options and driving the aorto-iliac occlusive disease treatment market forward.
Growing Geriatric Population: The rising proportion of older adults globally has led to an increase in aorto-iliac occlusive disease cases. Older adults naturally experience wear and tear in their blood vessels. This makes them more vulnerable to arterial blockages and other associated complications. This population group often requires regular check-ups and interventional procedures for effective management of their conditions. Thus, the rising geriatric population is fueling the demand for aorto-iliac occlusive disease treatment.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/aorto-iliac-occlusive-disease-treatment-market/request-for-discount-pricing
Market Key Players:
The competitive landscape of the aorto-iliac occlusive disease treatment market is characterized by rising collaborations and innovation-led growth. Players are focusing on strategic initiatives to improve their market positioning. A few of the major market participants are:
• Abbott
• BD.
• Bentley InnoMed
• Biotronik SE & Co KG
• Boston Scientific Corporation
• Cook
• Getinge AB
• iVascular
• Medtronic
• Scitech Medical
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Aorto-Iliac Occlusive Disease Treatment Industry Developments
• March 2024: Cook Medical entered into a distribution agreement with Getinge to enhance access to the iCast covered stent system in the United States. The device is used in the treatment of iliac artery disease, supporting improved patient care and availability.
• January 2024: Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval from China's National Medical Products Administration (NMPA) for its ZYLOX Peripheral Venous Stent System. This system is designed to treat lower limb and pelvic venous disorders associated with iliac vein compression.
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/aorto-iliac-occlusive-disease-treatment-market
Market Segmentation:
By Device Type Outlook (Revenue, USD Billion, 2020-2034)
• Endovascular Devices
o Balloon Angioplasty Devices
o Atherectomy Systems
o Stents
• Surgical Devices
By Procedure Outlook (Revenue, USD Billion, 2020-2034)
• Endovascular Procedures
• Hybrid Procedures
• Open Surgical Procedures
By End Use Outlook (Revenue, USD Billion, 2020-2034)
• Hospitals
• Outpatient Facilities
• Others
Regional Analysis
North America accounted for a significant market share in 2024. This is primarily due to the region's strong reimbursement frameworks and widespread use of advanced endovascular procedures. The presence of a well-established healthcare infrastructure further contributes to the region's major market share.
Asia Pacific is projected to register the highest CAGR from 2025 to 2034, driven by expanding medical infrastructure, rising healthcare access, and growing awareness of vascular conditions. The growing aging population and improved affordability of healthcare services further drive robust market growth in the region.
Browse More Research Reports:
MENA Gaucher Disease Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/middle-east-and-north-america-mena-gaucher-disease-treatment-market
Coagulation analyzer market:
https://www.polarismarketresearch.com/industry-analysis/coagulation-analyzer-market
Coagulation Reagent Market:
https://www.polarismarketresearch.com/industry-analysis/coagulation-reagent-market
Direct Oral Anticoagulants (DOACs) Device Market:
https://www.polarismarketresearch.com/industry-analysis/direct-oral-anticoagulants-doacs-device-market
Molecular Diagnostics For Sexually Transmitted Diseases Market:
https://www.polarismarketresearch.com/industry-analysis/molecular-diagnostics-for-sexually-transmitted-diseases-market
Topical Drugs Cdmo Market:
https://www.polarismarketresearch.com/industry-analysis/topical-drugs-cdmo-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aorto-Iliac Occlusive Disease Treatment Market Projected to Reach USD 3.56 Billion by 2034, Expanding at a CAGR of 5.3% here
News-ID: 4081215 • Views: …
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
